RANKL-induced osteoclastogenesis is suppressed by 4-O-methylhonokiol in bone marrow-derived macrophages.

about

RANKL-induced osteoclastogenesis is suppressed by 4-O-methylhonokiol in bone marrow-derived macrophages.

Item

http://www.wikidata.org/entity/Q50201971

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

RANKL-induced osteoclastogenes ...... ne marrow-derived macrophages.

@en

RANKL-induced osteoclastogenes ...... ne marrow-derived macrophages.

@nl

type

Item

label

RANKL-induced osteoclastogenes ...... ne marrow-derived macrophages.

@en

RANKL-induced osteoclastogenes ...... ne marrow-derived macrophages.

@nl

prefLabel

RANKL-induced osteoclastogenes ...... ne marrow-derived macrophages.

@en

RANKL-induced osteoclastogenes ...... ne marrow-derived macrophages.

@nl

P1476

RANKL-induced osteoclastogenes ...... ne marrow-derived macrophages.

@en

P2093

Eun-Cheol Kim

http://www.w3.org/2001/XMLSchema#string

Hyung-Mun Yun

http://www.w3.org/2001/XMLSchema#string

Ji-Youn Kim

http://www.w3.org/2001/XMLSchema#string

Jin Tae Hong

http://www.w3.org/2001/XMLSchema#string

Kyung-Ran Park

http://www.w3.org/2001/XMLSchema#string

P2860

The novel cellular mechanism of human 5-HT6 receptor through an interaction with Fyn

Bone resorption by osteoclasts

Therapeutic applications of compounds in the Magnolia family

Osteoclast differentiation and activation

Genetic regulation of osteoclast development and function

Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts

Amelioration of Cognitive Dysfunction in APP/PS1 Double Transgenic Mice by Long-Term Treatment of 4-O-Methylhonokiol.

4-O-Methylhonokiol attenuates memory impairment in presenilin 2 mutant mice through reduction of oxidative damage and inactivation of astrocytes and the ERK pathway.

Selective estrogen-receptor modulators -- mechanisms of action and application to clinical practice.

Drugs used to treat osteoporosis: the critical need for a uniform nomenclature based on their action on bone remodeling.

P2888

s12272-017-0932-z

P304

933-942

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12272-017-0932-Z

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-07-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28736799

http://www.w3.org/2001/XMLSchema#string